Evidence of increased serotonin-1A receptor binding in type 2 diabetes: a positron emission tomography study

[1]  Dennis S. Charney,et al.  Neurobiology of Mental Illness , 2004 .

[2]  Shitij Kapur,et al.  Serotonin 5-HT1A Receptor Binding Potential Declines with Age as Measured by [11C]WAY-100635 and PET , 2001, Neuropsychopharmacology.

[3]  Chester A. Mathis,et al.  Gender-specific aging effects on the serotonin 1A receptor , 2001, Brain Research.

[4]  D L Alexoff,et al.  A Strategy for Removing the Bias in the Graphical Analysis Method , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  M N Cantwell,et al.  Does cerebral blood flow decline in healthy aging? A PET study with partial-volume correction. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  M Slifstein,et al.  Validation and Reproducibility of Measurement of 5-HT1A Receptor Parameters with [carbonyl-11C]WAY-100635 in Humans: Comparison of Arterial and Reference Tissue Input Functions , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[7]  J. Vry,et al.  Effects of selected serotonin 5-HT1 and 5-HT2 receptor agonists on feeding behavior: possible mechanisms of action , 2000, Neuroscience & Biobehavioral Reviews.

[8]  A. García-Osta,et al.  Effect of p‐Chloroamphetamine on 5‐HT1A and 5‐HT7 Serotonin Receptor Expression in Rat Brain , 2000, Journal of neurochemistry.

[9]  P A Sargent,et al.  Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. , 2000, Archives of general psychiatry.

[10]  O. Sabri,et al.  Influence of diabetes mellitus on regional cerebral glucose metabolism and regional cerebral blood flow , 2000, Nuclear medicine communications.

[11]  Thomas E. Nichols,et al.  Comparative evaluation of MR-based partial-volume correction schemes for PET. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  D. Kupfer,et al.  Pet imaging of serotonin 1A receptor binding in depression , 1999, Biological Psychiatry.

[13]  B. McEwen,et al.  Neurological Changes Induced by Stress in Streptozotocin Diabetic Rats , 1999, Annals of the New York Academy of Sciences.

[14]  P. Blier,et al.  Autoregulation of serotonin neurons: role in antidepressant drug action. , 1999, Pharmacological reviews.

[15]  M. Limburg,et al.  Cerebrovascular reactivity and reserve capacity in type II diabetes mellitus. , 1999, Journal of diabetes and its complications.

[16]  A. McCall,et al.  Regulation of GLUT-3 glucose transporter in the hippocampus of diabetic rats subjected to stress. , 1999, American journal of physiology. Endocrinology and metabolism.

[17]  I. Liberzon,et al.  Serotonin 1A receptor messenger RNA regulation in the hippocampus after acute stress , 1999, Biological Psychiatry.

[18]  G. Biessels,et al.  Cerebral complications of diabetes: clinical findings and pathogenetic mechanisms. , 1999, The Netherlands journal of medicine.

[19]  V. Mohan,et al.  Glycosylated Hemoglobin Levels and New Diagnostic Criteria , 1998, Diabetes Care.

[20]  Roger N. Gunn,et al.  Tracer Kinetic Modeling of the 5-HT1AReceptor Ligand [carbonyl-11C]WAY-100635 for PET , 1998, NeuroImage.

[21]  M. Buhot,et al.  Differential effects of serotonin (5-HT) lesions and synthesis blockade on neuropeptide-Y immunoreactivity and 5-HT1A, 5-HT1B/1D and 5-HT2A/2C receptor binding sites in the rat cerebral cortex , 1998, Brain Research.

[22]  P. Marsden,et al.  Regional Differences in Cerebral Blood Flow and Glucose Utilization in Diabetic Man: The Effect of Insulin , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[23]  M. Roy,et al.  Increased urinary-free cortisol outputs in diabetic patients. , 1998, Journal of diabetes and its complications.

[24]  Paul J. Harrison,et al.  [3H]WAY–100635 for 5–HT1A receptor autoradiography in human brain: a comparison with [3H]8–OH–DPAT and demonstration of increased binding in the frontal cortex in schizophrenia , 1997, Neurochemistry International.

[25]  S. Augood,et al.  Monoamine Transporter Gene Expression in the Central Nervous System in Diabetes Mellitus , 1997, Journal of neurochemistry.

[26]  A. Ottani,et al.  Streptozotocin-induced diabetes provokes changes in serotonin concentration and on 5-HT1A and 5-HT2 receptors in the rat brain. , 1997, Life sciences.

[27]  H. Meltzer,et al.  The Effect of Streptozotocin-Induced Diabetes on Dopamine2, Serotonin1A and Serotonin2A Receptors in the Rat Brain , 1997, Neuropsychopharmacology.

[28]  H. Wikström,et al.  Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]WAY-100635 , 1997, Brain Research.

[29]  J. McArdle,et al.  Low-affinity sulfonylurea binding sites reside on neuronal cell bodies in the brain , 1997, Brain Research.

[30]  Ryan Cm,et al.  Effects of Diabetes Mellitus on Neuropsychological Functioning: A Lifespan Perspective. , 1997 .

[31]  P A Sargent,et al.  Exquisite delineation of 5-HT1A receptors in human brain with PET and [carbonyl-11 C]WAY-100635. , 1996, European journal of pharmacology.

[32]  I A Cliffe,et al.  A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635. , 1995, European journal of pharmacology.

[33]  P. Goodnick,et al.  Treatment of depression in patients with diabetes mellitus. , 1995, The Journal of clinical psychiatry.

[34]  G. Reaven,et al.  Verbal Learning and/or Memory Improves with Glycemic Control in Older Subjects with Non‐Insulin‐Dependent Diabetes Mellitus , 1993, Journal of the American Geriatrics Society.

[35]  Ting-kai Li,et al.  Greater abundance of serotonin1A receptor in some brain areas of alcohol-preferring (P) rats compared to nonpreferring (NP) rats , 1993, Pharmacology Biochemistry and Behavior.

[36]  H. Tuokko,et al.  The effect of improved glycemic control on cognitive functions in the elderly patient with diabetes. , 1993, Journal of gerontology.

[37]  J. Mazziotta,et al.  MRI‐PET Registration with Automated Algorithm , 1993, Journal of computer assisted tomography.

[38]  A. McCall.  The Impact of Diabetes on the CNS , 1992, Diabetes.

[39]  R. Clouse,et al.  Depression in adults with diabetes. , 1992, Diabetes care.

[40]  Anat Biegon,et al.  Autoradiographic analysis of serotonin 5-HT1A receptor binding in the human brain postmortem: effects of age and alcohol , 1991, Brain Research.

[41]  David J. Schlyer,et al.  Graphical Analysis of Reversible Radioligand Binding from Time—Activity Measurements Applied to [N-11C-Methyl]-(−)-Cocaine PET Studies in Human Subjects , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[42]  S. Stone-Elander,et al.  D-[U-11C]glucose uptake and metabolism in the brain of insulin-dependent diabetic subjects. , 1990, The American journal of physiology.

[43]  S. Stone-Elander,et al.  Cerebral blood flow and substrate utilization in insulin-treated diabetic subjects. , 1990, The American journal of physiology.

[44]  J. Palacios,et al.  Serotonin receptors in the human brain—IV. Autoradiographic mapping of serotonin-2 receptors , 1987, Neuroscience.

[45]  S. Leu,et al.  Alterations in Physiologic Functions and in Brain Monoamine Content in Streptozocin-Diabetic Rats , 1986, Diabetes.

[46]  S. Luthra,et al.  Journal of Cerebral Blood Flow and Metabolism Regional Cerebral Glucose Transport in Insulin-dependent Diabetic Patients Studied Using [11c]3-0-methyl-d-glucose and Positron Emission Tomography , 2022 .

[47]  M. Mintun,et al.  A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography , 1984, Annals of neurology.

[48]  M. Mintun,et al.  Brain blood flow measured with intravenous H2(15)O. II. Implementation and validation. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[49]  S. Kuentzel,et al.  Tissue distribution of streptozotocin (NSC-85998). , 1974, Cancer chemotherapy reports.

[50]  R. Wurtman,et al.  Brain serotonin content: physiological regulation by plasma neutral amino acids. , 1997, Science.

[51]  A. Berger.  FUNDAMENTALS OF BIOSTATISTICS , 1969 .